Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The acquisition includes the lead candidate CBB-120, a dual-payload antibody-dru...
Product priced lower than innovator drug and introduced for type 2 diabetes tre...
Partnership supports drug discovery programmes for obesity and metabolic diseas...
ANDA approval with CGT designation grants six-month exclusivity for parenteral ...
Campaign highlights association as principal sponsor and health partner during ...
The approval makes Filspari the first and only FDA-approved medicine to treat FS...
The treatment targets adult patients with ES-SCLC who have experienced disease p...
Partnership applies AI to drug discovery and operations across Novo Nordisk and...
Announces strategic diversity initiative to add 800 - 1,000 women employees acr...
India is poised to lead the global pharma landscape with a focus on biosimilars...
Telix and Regeneron Pharmaceuticals have entered a partnership for the developme...
The decision affects Replimune’s lead product candidate, which is based on a gen...
GlobalData highlights shift towards localised manufacturing, inventory security...
Catalyst training programme launched to link academic learning with industry re...
Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction wi...
A new class of drugs is reshaping global health,but India’s generics wave could...
